These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27992572)

  • 1. Usefulness of DNA Methylation Levels in COASY and SPINT1 Gene Promoter Regions as Biomarkers in Diagnosis of Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    Kobayashi N; Shinagawa S; Nagata T; Shimada K; Shibata N; Ohnuma T; Kasanuki K; Arai H; Yamada H; Nakayama K; Kondo K
    PLoS One; 2016; 11(12):e0168816. PubMed ID: 27992572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased blood COASY DNA methylation levels a potential biomarker for early pathology of Alzheimer's disease.
    Kobayashi N; Shinagawa S; Niimura H; Kida H; Nagata T; Tagai K; Shimada K; Oka N; Shikimoto R; Noda Y; Nakajima S; Mimura M; Shigeta M; Kondo K
    Sci Rep; 2020 Jul; 10(1):12217. PubMed ID: 32699290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Biomarkers Based on DNA Methylation in the NCAPH2/LMF2 Promoter Region for Diagnosis of Alzheimer's Disease and Amnesic Mild Cognitive Impairment.
    Kobayashi N; Shinagawa S; Nagata T; Shimada K; Shibata N; Ohnuma T; Kasanuki K; Arai H; Yamada H; Nakayama K; Kondo K
    PLoS One; 2016; 11(1):e0146449. PubMed ID: 26742120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of Peripheral BDNF Promoter Methylation Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Longitudinal Study.
    Xie B; Xu Y; Liu Z; Liu W; Jiang L; Zhang R; Cui D; Zhang Q; Xu S
    J Alzheimers Dis; 2017; 56(1):391-401. PubMed ID: 27935556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA Methylation and Tag SNPs of the BDNF Gene in Conversion of Amnestic Mild Cognitive Impairment into Alzheimer's Disease: A Cross-Sectional Cohort Study.
    Xie B; Liu Z; Liu W; Jiang L; Zhang R; Cui D; Zhang Q; Xu S
    J Alzheimers Dis; 2017; 58(1):263-274. PubMed ID: 28387675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in the IgG avidity index due to herpes simplex virus type 1 reactivation and its relationship with cognitive function in amnestic mild cognitive impairment and Alzheimer's disease.
    Kobayashi N; Nagata T; Shinagawa S; Oka N; Shimada K; Shimizu A; Tatebayashi Y; Yamada H; Nakayama K; Kondo K
    Biochem Biophys Res Commun; 2013 Jan; 430(3):907-11. PubMed ID: 23261465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation in the NCAPH2/LMF2 promoter region is associated with hippocampal atrophy in Alzheimer's disease and amnesic mild cognitive impairment patients.
    Shinagawa S; Kobayashi N; Nagata T; Kusaka A; Yamada H; Kondo K; Nakayama K
    Neurosci Lett; 2016 Aug; 629():33-37. PubMed ID: 27356276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High avidity HSV-1 antibodies correlate with absence of amnestic Mild Cognitive Impairment conversion to Alzheimer's disease.
    Agostini S; Mancuso R; Baglio F; Cabinio M; Hernis A; Costa AS; Calabrese E; Nemni R; Clerici M
    Brain Behav Immun; 2016 Nov; 58():254-260. PubMed ID: 27470229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations Between Levels of Peripheral NCAPH2 Promoter Methylation and Different Stages of Alzheimer's Disease: A Cross-Sectional Study.
    Hao SW; Li TR; Han C; Han Y; Cai YN
    J Alzheimers Dis; 2023; 92(3):899-909. PubMed ID: 36806511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered microbiomes distinguish Alzheimer's disease from amnestic mild cognitive impairment and health in a Chinese cohort.
    Liu P; Wu L; Peng G; Han Y; Tang R; Ge J; Zhang L; Jia L; Yue S; Zhou K; Li L; Luo B; Wang B
    Brain Behav Immun; 2019 Aug; 80():633-643. PubMed ID: 31063846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VP26, a herpes simplex virus type 1 capsid protein, increases DNA methylation in
    Osaka R; Kobayashi N; Shimada K; Ishii A; Oka N; Kondo K
    Brain Behav Immun Health; 2022 Dec; 26():100545. PubMed ID: 36345321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer's disease and implicate its dynamic role in disease progression.
    Wang Q; Chen Y; Readhead B; Chen K; Su Y; Reiman EM; Dudley JT
    Clin Epigenetics; 2020 Dec; 12(1):189. PubMed ID: 33298155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of peripheral blood DNA methylation level with Alzheimer's disease progression.
    Li QS; Vasanthakumar A; Davis JW; Idler KB; Nho K; Waring JF; Saykin AJ;
    Clin Epigenetics; 2021 Oct; 13(1):191. PubMed ID: 34654479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous K-Complexes may be biomarkers of the progression of amnestic mild cognitive impairment.
    Liu S; Pan J; Lei Q; He L; Zhong B; Meng Y; Li Z
    Sleep Med; 2020 Mar; 67():99-109. PubMed ID: 31918124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI.
    Vos SJ; van Rossum IA; Verhey F; Knol DL; Soininen H; Wahlund LO; Hampel H; Tsolaki M; Minthon L; Frisoni GB; Froelich L; Nobili F; van der Flier W; Blennow K; Wolz R; Scheltens P; Visser PJ
    Neurology; 2013 Mar; 80(12):1124-32. PubMed ID: 23446677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution and clinical impact of apolipoprotein E4 in subjective memory impairment and early mild cognitive impairment.
    Cho H; Kim YE; Chae W; Kim KW; Kim JW; Kim HJ; Na DL; Ki CS; Seo SW
    Sci Rep; 2020 Aug; 10(1):13365. PubMed ID: 32770103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Androgens and Gonadotropins with Amnestic Mild Cognitive Impairment and Probable Alzheimer's Disease in Chinese Elderly Men.
    Li Y; Li S; Xu S; Yu H; Tang L; Liu X; Wang X; Zhang Y; Zhang K; Mi S; Chen M; Cui H
    J Alzheimers Dis; 2020; 78(1):277-290. PubMed ID: 32986665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic inflammasome activation and pyroptosis associate with the progression of amnestic mild cognitive impairment and Alzheimer's disease.
    Rui W; Xiao H; Fan Y; Ma Z; Xiao M; Li S; Shi J
    J Neuroinflammation; 2021 Dec; 18(1):280. PubMed ID: 34856990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep spindles, K-complexes, limb movements and sleep stage proportions may be biomarkers for amnestic mild cognitive impairment and Alzheimer's disease.
    Liu S; Pan J; Tang K; Lei Q; He L; Meng Y; Cai X; Li Z
    Sleep Breath; 2020 Jun; 24(2):637-651. PubMed ID: 31786748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.
    Caminiti SP; Ballarini T; Sala A; Cerami C; Presotto L; Santangelo R; Fallanca F; Vanoli EG; Gianolli L; Iannaccone S; Magnani G; Perani D;
    Neuroimage Clin; 2018; 18():167-177. PubMed ID: 29387532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.